Analyzing 80 cases of conventional percutaneous nephrolithotomy A Retrospective Study

Objective:  The goal of this study is to provide information on the safety and efficacy of percutaneous nephrolithotomy as a kidney stone treatment method in tertiary care facilities. Material and methods: A retrospective study was out from June 2022 to July 2023 at the urology department of the Ikd Peshawar  This retrospective study included all patients who had percutaneous nephrolithotomy in the urology unit between June 2022 and July 2023. We analysed data that was retrospectively collected from the medical record system using IBM SPSS version 28. Results: The study included 80 patients, with 67.3% being male and 32.7% being female. A kidney stone history was present in 55% of the patients. As a result of pre-operative ultrasound, 54.3% of patients had several stones, 40.1% had one stone, 3.7% had staghorn stones, 1.2% had a duplex system, and 0.6% (n=1) had a horseshoe kidney. The majority (60%), with stone sizes between 15 and 30 mm, were less than 15 mm, while a sizable minority (16.7%) were larger than 30 mm. Stones were most often found in the renal pelvis (46.3% of cases), lower pole (18.5% of cases), pelvis and lower pole together (16.3% of cases), and staghorn (7.3%). The average hemoglobin level dropped by 1.1 g/dl between pre- and post-operative measurements, from 12.9 g/dl to 11.8 g/dl. Conclusion: A high clearance rate and manageable complication rate may be achieved using percutaneous nephrolithotomy, an efficient treatment for a variety of stone sizes and locations in the kidneys that are abnormal